These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1873816)

  • 1. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
    Isaacs WB; Carter BS; Ewing CM
    Cancer Res; 1991 Sep; 51(17):4716-20. PubMed ID: 1873816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
    Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
    Chen YM; Chen PL; Arnaiz N; Goodrich D; Lee WH
    Oncogene; 1991 Oct; 6(10):1799-805. PubMed ID: 1923505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ
    Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.
    Gurova KV; Rokhlin OW; Budanov AV; Burdelya LG; Chumakov PM; Cohen MB; Gudkov AV
    Cancer Res; 2003 Jun; 63(11):2905-12. PubMed ID: 12782597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE).
    Schlechte HH; Schnorr D; Löning T; Rudolph BD; Pohrt UM; Loening SA
    J Urol; 1997 Mar; 157(3):1049-53. PubMed ID: 9072541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
    Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 is mutated in a subset of advanced-stage prostate cancers.
    Bookstein R; MacGrogan D; Hilsenbeck SG; Sharkey F; Allred DC
    Cancer Res; 1993 Jul; 53(14):3369-73. PubMed ID: 8324747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes.
    Sharma S; Schwarte-Waldhoff I; Oberhuber H; Schäfer R
    Cell Growth Differ; 1993 Oct; 4(10):861-9. PubMed ID: 8274455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
    Buttgereit P; Schakowski F; Märten A; Brand K; Renoth S; Ziske C; Schöttker B; Ebert O; Schroers R; Schmidt-Wolf IG
    Cancer Gene Ther; 2001 Jun; 8(6):430-9. PubMed ID: 11498763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53.
    Bajgelman MC; Strauss BE
    Prostate; 2006 Sep; 66(13):1455-62. PubMed ID: 16741917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
    Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Friend virus induced murine erythroleukaemia: the p53 locus.
    Johnson P; Benchimol S
    Cancer Surv; 1992; 12():137-51. PubMed ID: 1638545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
    Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
    Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
    Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
    Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
    Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
    Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of wild-type p53 in the enhancement of camptothecin cytotoxicity against human prostate tumor cells.
    Arah IN; Song K; Seth P; Cowan KH; Sinha BK
    Anticancer Res; 1998; 18(3A):1845-9. PubMed ID: 9673414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth suppression of normal mammary epithelial cells by wild-type p53.
    Merlo GR; Venesio T; Taverna D; Marte BM; Callahan R; Hynes NE
    Oncogene; 1994 Feb; 9(2):443-53. PubMed ID: 8290256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.